陈鹏,郭瑞敏,孙燕妮

• 1:上海中医药大学附属普陀医院

摘要(Abstract)：

感染性休克是临床各科常见的急危重症之一,因患者血流动力学指标不稳定,微循环障碍,组织器官严重灌注不足,极易并发多器官功能衰竭而死亡,临床表现为机体阴阳失衡,气血逆乱,脏腑衰竭等厥脱证候,病情十分凶险。中成药参附注射液具有回阳救逆、益气固脱的作用,广泛应用于临床。近年来研究表明参附注射液具有改善感染性休克患者血流动力学的作用,显著降低临床死亡率。本文旨在为参附注射液对感染性休克患者的血流动力学研究进行综述,以期为临床治疗提供参考。

关键词(KeyWords)： 参附注射液;感染性休克;血流动力学

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目(81573901)

作者(Author): 陈鹏,郭瑞敏,孙燕妮

参考文献(References)：

• [1]Charrier JA,Steen CL,Borrero E.Severe sepsis and septic shock cases meeting guidelines among patients in a University Hospital Setting[J].The Journal of the Louisiana State Medical Society:official organ of the Louisiana State Medical Society,2017,169(2):57.
• [2]Rhodes A,Evans LE,Alhazzani W,et al.Surviving sepsis campaign:international guidelines for management of sepsis and septic shock:2016[J].Intensive care medicine,2017,43(3):304-377.
• [3]Thwaites CL,Lundeg G,Dondorp AM.Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings[J].Intensive care medicine,2016,42(12):2040-2042.
• [4]田鲜美,王玫,任传云,等.参附注射液治疗脓毒症休克(阳脱证)的临床疗效观察[J].北京中医药,2017,36(1):88-91.
• [5]Capp R,Horton CL,Takhar SS,et al.Predictors of patients who present to the emergency department with sepsis and progress to septic shock between 4 and 48 hours of emergency department arrival[J].Critical care medicine,2015,43(5):983-988.
• [6]Zhang L,Zhu G,Han L,et al.Early goal-directed therapy in the management of severe sepsis or septic shock in adults:a meta-analysis of randomized controlled trials[J].BMC medicine,2015,13(1):71.
• [7]中国医师协会急诊医师分会.中国急诊感染性休克临床实践指南[J].中华急诊医学杂志,2016,25(3):274-287.
• [8]张仲林,钟玲,臧志和.参附注射液的临床应用与药理作用研究[J].西南国防医药,2008,18(3):454-457.
• [9]Xiao P,Wang F,Feng G,et al.A pharmacophylogenetic study of{\sl Aconitum}L.(Ranunculaceae)from China[J].Acta Phytotaxonomica Sinica,2006,44(1):1-46.
• [10]Yue H,Pi Z,Song F,et al.Studies on the aconitine-type alkaloids in the roots of Aconitum Carmichaeli Debx.by HPLC/ESIMS/MS(n)[J].Talanta,2009,77(5):1800-1807.
• [11]孙晓霞,崔新明,王健春,等.人参二醇皂苷对感染性休克大鼠血清心肌酶和心肌超微结构的影响[J].中国老年学杂志,2010,30(15):2139-2141.
• [12]陈信义,李峨,侯丽,等.乌头类生物碱研究进展与应用前景评述[J].中国中医药信息杂志,2004,11(10):922-923.
• [13]黄琼,徐伟建.参附注射液对压力后负荷性急性心衰大鼠血流动力学的影响[J].实用中西医结合临床,2005,5(2):6-7.
• [14]王华平.参附注射液治疗休克41例临床观察[J].中国民族民间医药,2015,24(4):91.
• [15]岳胜,朱平,岳磊,等.参附注射液在感染性休克的疗效分析[J].北方药学,2017,14(1):100-101.
• [16]黄小洵.应用Pi CCO评估参附注射液对感染性休克患者血流动力学的影响及预后[D].广州:广州中医药大学,2016.
• [17]卓道勤,吕国焰,闵磊,等.参附注射液对感染性休克早期血流动力学紊乱干预性研究[J].中国中医急症,2011,20(12):2005.
• [18]崔颖,戴琳琳.参附注射液治疗感染性休克疗效及对血流动力学的影响[J].现代中西医结合杂志,2016,25(19):2120-2122.
• [19]周凤鑫.组织血液灌注与微循环的病理生理[J].外科理论与实践,2008,13(1):13-19.
• [20]唐笑迪,孙晓霞,王健春.人参二醇组皂苷对感染性休克大鼠血液流变性及微循环的影响[J].中国老年学杂志,2009,29(23):3044-3046.
• [21]乔宋璇,卓道勤,张丹阳,等.参附注射液对感染性休克早期微循环的影响[J].中国中医急症,2016,25(1):135-136.
• [22]王俊英,谯明,彭艳,等.参附注射液对感染性休克(高排低阻证)血流动力学及组织灌注改善作用的临床观察[J].中国中医急症,2015,24(10):1827-1828.
• [23]Yang F,Zheng Y,Li D,et al.Effect of Shenfu injection on microcirculation[J].Journal ofbiomedical engineering,2003,20(1):91-94,100.
• [24]温穗文,郭晓燕,黄旭君,等.限制性液体复苏对产后失血性休克患者血流动力学及凝血功能的影响[J].广东医学,2014,35(21):3335-3337.
• [25]刘继宝.大剂量参附注射液对急诊多发伤合并休克凝血功能的影响[J].河南中医,2014,34(11):2164-2165.
• [26]陈文元,张英俭,梁伟伟,等.参附注射液对轻、中度创伤失血性休克患者凝血功能的影响[J].中国现代医生,2013,51(3):81-83.
• [27]杜健,汪晨净,景志敏.心肌缺血再灌注损伤中钙超载和氧自由基作用机制研究[J].卫生职业教育,2009,27(11):121-123.
• [28]Jeroudi MO,Hartley CJ,Bolli R.Myocardial reperfusion injury:role of oxygen radicalsand potential therapy with antioxidants[J].American Journal of Cardiology,1994,73(6):2B.
• [29]司良毅,张远慧.钙超载、氧自由基和中性粒细胞与心肌缺血再灌注损伤[J].重庆医学,1995,24(3):177-178.
• [30]Zhen SY,Xu JG,Zhao ZZ.The protective effect of shenfu injection on myocardium against ischemia reperfusion injury in rats[J].Zhongguo Zhong xi yi jie he za zhi,2004,24(6):541-544.
• [31]Zhang BJ,Wang YL,Wang CY.Effect of Shenfu injection on nuclear factor-kappa B during myocardial ischemia/reperfusion injury in rats[J].Chinese Journal of Traumatology,2005,8(4):200-204.
• [32]Zheng SY,Sun J,Zhao X,et al.Protective effect of Shen-Fu on myocardial ischemia-reperfusion injury in rats[J].The American journal of Chinese medicine,2004,32(2):209-220.
• [33]Li Y,Wang Y,Li J,et al.Protective effect of shenfu injection on kidney against ischemia-reperfusion injury in rats[J].Journal of Sichuan University.Medical science edition,2011,42(1):41-43,77.
• [34]Long SQ,Liao GY,He WF,et al.Influence of Shenfu Injection on the quality of life of lung cancer patients receiving chemotherapy[J].Journal of Southern Medical University,2011,31(12):2090.
• [35]Long SQ,Liao GY,He WF,et al.Influence of Shenfu Injection on the quality of life of lung cancer patients receiving chemotherapy[J].Journal of Southern Medical University,2011,31(12):2090.
• [36]Yang SL,Feng ZQ,Wu LS,et al.Shenfu injection prevents kidney from acute ischemia-reperfusion injury in rabbits[J].Chinese Journal of Pathophysiology,2003,19:353-356.
• [37]胡刚,刘先义,夏中元,等.参附注射液对缺血再灌注大鼠肠粘膜NF-κB、ICAM-1、TNF-α、i NOS表达的影响[J].同济大学学报:医学版,2003,24(5):381-384.
• [38]Zhen SY,Xu JG,Zhao ZZ.The protective effect of shenfu injection on myocardium against ischemia reperfusion injury in rats[J].Zhongguo Zhong xi yi jie he za zhi,2004,24(6):541-544.
• [39]NI J,SHI Y,LI L,et al.Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway[J].Evidence-Based Complementary and Alternative Medi-cine,2017,2017:1-16.
• [40]Wang ZF,Zhong L,Li YS.The protective effects of Shenfu injection on the global cerebral ischemia/reperfusion injury of rats[J].Zhongguo ying yong sheng li xue za zhi,2012,28(5):462-465.
• [41]李洁.参附注射液对呼吸衰竭患者机械通气时间临床研究[J].辽宁中医药大学学报,2013,15(2):160-162.
• [42]林孟相,吴军,庄荣,等.大黄联合参附注射液对急性呼吸窘迫综合征患者呼吸功能的影响研究[J].中华中医药学刊,2013,31(6):1465-1467.
• [43]陈如杰,张明,潘利伟,等.参附注射液对感染性休克患者炎症反应及免疫功能影响的临床对照研究[J].中华中医药学刊,2015,33(10):2461-2464.
• [44]Li Y,Wang Y,Li J,et al.Protective effect of shenfu injection on kidney against ischemiareperfusion injury in rats[J].Sichuan Da Xue Xue Bao Yi Xue Ban,2011,42(1):41-43,77.
• [45]胡剑江.参附注射液对内毒素休克大鼠肝脏的保护作用及机制研究[D].北京:北京中医药大学,2007.